Skip to content
Screener

Opko Health OPK EV / EBITDA

EV / EBITDA at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
13.2×+0.3×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
4.3×-1.7×
Exelixis logo
ExelixisEXEL
11.6×-1.3×
ALN
Alnylam PharmaceuticalsALNY
36.7×—
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
10.1×-0.2×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0×0.0×
Current ratio3.3×-0.1×

Where this comes from

Calculated from Opko Health’s reported figures.

enterprise value/ebitda=28.5×

Based on the most recent quarter.

The source filing: Opko Health’s 10-Q, filed July 27, 2026. Open the filing →

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090

FAQ

What is Opko Health's EV / EBITDA?
Opko Health (OPK) reported EV / EBITDA of 28.5× in Q2 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Opko Health's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude